New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q1 2024 call → NOWe need to determine if management indicates that the economic terms of new business have stepped up meaningfully above the company's own recent norm, and that this improvement has only begun to flow into reported results. The transcript discusses portfolio purchasing, collections, pricing, returns, etc. Management talks about strong purchasing in the U.S. at attractive returns, record deployments, and that they are allocating capital to highest returns. They mention that pricing in the U.S. has adjusted to higher funding costs, while Europe has not. They also mention that they expect operating leverage and that 2024 is a turning point. However, the question is specifically about the terms of new business (e.g., prices, rates, spreads) improving meaningfully above the company's own recent norm, and that this improvement is early in the numbers. Management says: "We deployed a record $237 million in the U.S. at strong returns" and "purchasing conditions in the U.S. market remain highly favorable, with continued strong growth in U.S. market supply and attractive pricing." They also say "the most recent delinquency data supports our expectation that 2024 will be another year of record portfolio sales." They mention that they are being selective in Europe due to pricing not reflecting higher funding costs. They also say "we continue to allocate the vast majority of our capital to the U.S. market" and "we expect to continue to deploy at current low levels until the returns in Cabot's markets become more attractive." They also mention that they have been building higher coupon into bidding strategy since rates started to rise. They say "In the U.S., however, market pricing has indeed adjusted to this higher cost of funding." So they are saying that the terms (pricing) on new purchases are better than before? They are buying at strong returns, but is that a step-up above their own recent norm? They say "record U.S. deployments" and "strong returns" but they don't explicitly compare to their own recent terms. They do say that they are allocating more to U.S. because returns are higher there. But the question is about the terms of new business improving meaningfully above the company's own recent norm. They mention that they are buying at attractive pricing, but is that a step-up? They also say that they expect collections to grow and that 2024 is a turning point.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...